FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tomozumi Imamichi

Research Profile

Living Beings

HIV-1

Physiology

Chemicals & Drugs

Disorders

HIV Infections

Anatomy

Genes & Molecular Sequences

Molecular Structure

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sanjay Swaminathan; Bao Tran; Jun Yang; Yongmei Zhao; Xin Zheng; Michael W Baseler; Xiaojun Hu; Dawei Huang; Yuliya Kriga; H Clifford Lane; Richard A Lempicki; Jyoti Shetty; Robert Stephens; Tomozumi Imamichi
Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties.
Lue Dai; Robin L Dewar; Ronald L Hornung; DaWei Huang; Joseph W Adelsberger; Kelsey A Canizales; Qian Chen; H Clifford Lane; Richard A Lempicki; Kristy B Lidie; Stephen J Lockett; Tauseef Rehman; Yanmei Wang; Jun Yang; Xin Zheng; Tomozumi Imamichi
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.
Qian Chen; Lue Dai; Ronald L Hornung; Xiaojun Hu; Da Wei Huang; Richard A Lempicki; Hongyan Sui; Sanjay Swaminathan; Yanmei Wang; De Yang; Jun Yang; Tomozumi Imamichi
Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tomozumi Imamichi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sanjay Swaminathan; Bao Tran; Jun Yang; Yongmei Zhao; Xin Zheng; Michael W Baseler; Xiaojun Hu; Dawei Huang; Yuliya Kriga; H Clifford Lane; Richard A Lempicki; Jyoti Shetty; Robert Stephens; Tomozumi Imamichi
Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties.
Biochemical and biophysical research communications 2013;434(2):228-34.
2013: Lue Dai; Robin L Dewar; Ronald L Hornung; DaWei Huang; Joseph W Adelsberger; Kelsey A Canizales; Qian Chen; H Clifford Lane; Richard A Lempicki; Kristy B Lidie; Stephen J Lockett; Tauseef Rehman; Yanmei Wang; Jun Yang; Xin Zheng; Tomozumi Imamichi
IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.
The Journal of experimental medicine 2013;210(3):517-34.
2013: Qian Chen; Lue Dai; Ronald L Hornung; Xiaojun Hu; Da Wei Huang; Richard A Lempicki; Hongyan Sui; Sanjay Swaminathan; Yanmei Wang; De Yang; Jun Yang; Tomozumi Imamichi
Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway.
PloS one 2013;8(3):e59194.
2012: Ahu Demir; Tomozumi Imamichi; Andrew Magis; Raphael M Oguariri; David A Ostrov; Ben M Dunn
Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells.
Antiviral therapy 2012;17(5):883-92.
2012: Tomozumi Imamichi; Brad Sherman; Jun Yang; Da Wei Huang; Richard A Lempicki
Interleukin-27 induces interferon-inducible genes: analysis of gene expression profiles using Affymetrix microarray and DAVID.
Methods in molecular biology (Clifton, N.J.) 2012;820():25-53.
2011: Yuichi Yoshimura; Yoshiko Yamazaki; Yukako Saito; Yoshihiro Natori; Tomozumi Imamichi; Hiroki Takahata
Synthesis of 5-thiodidehydropyranylcytosine derivatives as potential anti-HIV agents.
Bioorganic & medicinal chemistry letters 2011;21(11):3313-6.
2011: Xing Zhang; Terrence W Brann; Ming Zhou; Jun Yang; Raphael M Oguariri; Kristy B Lidie; Hiromi Imamichi; Da-Wei Huang; Richard A Lempicki; Michael Baseler; Timothy D Veenstra; Howard A Young; H Clifford Lane; Tomozumi Imamichi
Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN.
Journal of immunology (Baltimore, Md. : 1950) 2011;186(8):4541-5.
2010: Raphael M Oguariri; Joseph W Adelsberger; Michael W Baseler; Tomozumi Imamichi
Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.
Virus research 2010;153(2):269-76.
2010: Yuichi Yoshimura; Kazuhiro Asami; Tomozumi Imamichi; Tomoko Okuda; Kimiyasu Shiraki; Hiroki Takahata
Design and synthesis of isonucleosides constructed on a 2-oxa-6-thiabicyclo[3.2.0]heptane scaffold.
The Journal of organic chemistry 2010;75(12):4161-71.
2010: Astrid C Frank; Xiaozhen Zhang; Antonios Katsounas; Jennifer P Bharucha; Shyamasundaran Kottilil; Tomozumi Imamichi
Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2010;30(6):427-31.
2009: Da Wei Huang; Brad T Sherman; Xin Zheng; Jun Yang; Tomozumi Imamichi; Robert Stephens; Richard A Lempicki
Extracting biological meaning from large gene lists with DAVID.
Current protocols in bioinformatics / editoral board, Andreas D. Baxevanis ... [et al.] 2009;Chapter 13():Unit 13.11.
2008: Yuichi Yoshimura; Masatoshi Ohta; Tatsushi Imahori; Tomozumi Imamichi; Hiroki Takahata
A new entry to carbocyclic nucleosides: oxidative coupling reaction of cycloalkenylsilanes with a nucleobase mediated by hypervalent iodine reagent.
Organic letters 2008;10(16):3449-52.
2008: Tomozumi Imamichi; Jun Yang; Da-Wei Huang; Terrence W Brann; Brandie A Fullmer; Joseph W Adelsberger; Richard A Lempicki; Michael Baseler; H Clifford Lane
IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages.
AIDS (London, England) 2008;22(1):39-45.
2007: Veronique Nussenblatt; Mary McLaughlin; Catherine A Rehm; Richard A Lempicki; Terry Brann; Jun Yang; Michael A Proschan; Helene C Highbarger; Robin L Dewar; Tomozumi Imamichi; Chad Koratich; Avidan U Neumann; Henry Masur; Michael A Polis; Shyam Kottilil
Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.
AIDS research and human retroviruses 2007;23(11):1354-9.
2007: J Mohamad Fakruddin; Richard A Lempicki; Robert J Gorelick; Jun Yang; Joseph W Adelsberger; Alfonso J Garcia-Pineres; Ligia A Pinto; H Clifford Lane; Tomozumi Imamichi
Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.
Blood 2007;109(5):1841-9.
2007: Raphael M Oguariri; Terrence W Brann; Tomozumi Imamichi
Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors.
The Journal of biological chemistry 2007;282(6):3594-604.
2006: Terrence W Brann; Robin L Dewar; Min-Kan Jiang; Akram Shah; Kunio Nagashima; Julia A Metcalf; Judith Falloon; H Clifford Lane; Tomozumi Imamichi
Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness.
Journal of virology 2006;80(12):6136-45.
2005: Tomozumi Imamichi; Thomas P Conrads; Ming Zhou; Yuxin Liu; Joseph W Adelsberger; Timothy D Veenstra; H Clifford Lane
A transcription inhibitor, actinomycin D, enhances HIV-1 replication through an interleukin-6-dependent pathway.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):388-97.
2005: Irini Sereti; Hiromi Imamichi; Ven Natarajan; Tomozumi Imamichi; Meena S Ramchandani; Yunden Badralmaa; Steve C Berg; Julia A Metcalf; Barbara K Hahn; Jean M Shen; April Powers; Richard Davey; Joseph A Kovacs; Ethan M Shevach; H Clifford Lane
In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.
The Journal of clinical investigation 2005;115(7):1839-47.
2005: Elizabeth Johnston; Kathryn M Dupnik; Matthew J Gonzales; Mark A Winters; Soo-Yon Rhee; Tomozumi Imamichi; Robert W Shafer
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations.
AIDS (London, England) 2005;19(7):731-3.
2004: Paul L Boyer; Tomozumi Imamichi; Stefan G Sarafianos; Eddy Arnold; Stephen H Hughes
Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Journal of virology 2004;78(18):9987-97.
2004: Tomozumi Imamichi
Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors.
Current pharmaceutical design 2004;10(32):4039-53.
2003: Matthew J Gonzales; Elizabeth Johnson; Kathryn M Dupnik; Tomozumi Imamichi; Robert W Shafer
Colinearity of reverse transcriptase inhibitor resistance mutations detected by population-based sequencing.
Journal of acquired immune deficiency syndromes (1999) 2003;34(4):398-402.
2003: Tomozumi Imamichi; Michael A Murphy; Joseph W Adelsberger; Jun Yang; Catherine M Watkins; Steve C Berg; Michael Baseler; Richard A Lempicki; Jianhui Guo; Judith G Levin; H Clifford Lane
Actinomycin D induces high-level resistance to thymidine analogs in replication of human immunodeficiency virus type 1 by interfering with host cell thymidine kinase expression.
Journal of virology 2003;77(2):1011-20.
2002: Hiromi Imamichi; Tatsuhiko Igarashi; Tomozumi Imamichi; Olivia K Donau; Yasuyuki Endo; Yoshiaki Nishimura; Ronald L Willey; Anthony F Suffredini; H Clifford Lane; Malcolm Martin
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(21):13813-8.
2001: Tomozumi Imamichi; M A Murphy; Hiromi Imamichi; H Clifford Lane
Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles.
Journal of virology 2001;75(8):3988-92.
2000: Tomozumi Imamichi; Steve C Berg; Hiromi Imamichi; J C Lopez; Julia A Metcalf; Judith Falloon; H Clifford Lane
Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.
Journal of virology 2000;74(23):10958-64.
2000: Tomozumi Imamichi; T Sinha; Hiromi Imamichi; YM Zhang; Julia A Metcalf; Judith Falloon; H Clifford Lane
High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.
Journal of virology 2000;74(2):1023-8.
1997: YM Zhang; Hiromi Imamichi; Tomozumi Imamichi; H Clifford Lane; Judith Falloon; M B Vasudevachari; N P Salzman
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Journal of virology 1997;71(9):6662-70.